144 related articles for article (PubMed ID: 8266769)
21. [Sandostatin treatment in postoperative external digestive fistulae].
Munteanu D; Duca S; Vlad L; Părăian I; Togănel D; Iancu C; Pop F; Radu H; Puia C; Bălă O; Bud O; Nagy Z; Leucă D; Bordei R; Popazu R
Chirurgia (Bucur); 1998; 93(1):13-21. PubMed ID: 9567457
[TBL] [Abstract][Full Text] [Related]
22. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output.
Nubiola-Calonge P; Badía JM; Sancho J; Gil MJ; Segura M; Sitges-Serra A
Lancet; 1987 Sep; 2(8560):672-4. PubMed ID: 2887951
[TBL] [Abstract][Full Text] [Related]
23. [Treatment results of enterocutaneous fistulae in patients with cancer].
González-Avila G; Quezada-Ramírez ME; Jiménez Pardo E; Bello-Villalobos H
Rev Gastroenterol Mex; 2005; 70(2):158-63. PubMed ID: 16167491
[TBL] [Abstract][Full Text] [Related]
24. Role of octreotide and somatostatin in the treatment of intestinal fistulae.
Dorta G
Digestion; 1999; 60 Suppl 2():53-6. PubMed ID: 10207232
[TBL] [Abstract][Full Text] [Related]
25. Treatment of postoperative enterocutaneous fistulas with octreotide in two neonates.
Karabulut R; Karakuş C; Hirfanoğlu I; Turan O; Türkyilmaz Z; Sönmez K; Onal EE; Atalay Y; Başaklar AC
Eur J Pediatr Surg; 2008 Feb; 18(1):56-8. PubMed ID: 18302073
[TBL] [Abstract][Full Text] [Related]
26. Octreotide and enterocutaneous fistula closure in neonates and children.
Carrera-Guermeur N; Martín-Crespo RM; Ramírez HJ; Pantoja Á; Luque-Mialdea R
Eur J Pediatr; 2016 Mar; 175(3):305-12. PubMed ID: 26811298
[TBL] [Abstract][Full Text] [Related]
27. Successful closure of intestinal fistulae in an infant using the somatostatin analogue SMS 201-995.
Wallace AM; Newman K
J Pediatr Surg; 1991 Sep; 26(9):1097-100. PubMed ID: 1941488
[TBL] [Abstract][Full Text] [Related]
28. Are somatostatin analogues (octreotide and lanreotide) effective in promoting healing of enterocutaneous fistulas?
Gray M; Jacobson T
J Wound Ostomy Continence Nurs; 2002 Sep; 29(5):228-33. PubMed ID: 12510468
[No Abstract] [Full Text] [Related]
29. Systematic review and meta-analysis of the role of somatostatin and its analogues in the treatment of enterocutaneous fistula.
Stevens P; Foulkes RE; Hartford-Beynon JS; Delicata RJ
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):912-22. PubMed ID: 21814141
[TBL] [Abstract][Full Text] [Related]
30. Somatostatin in gastroenterology. More studies needed.
Carlson GL; Scott NA; Irving MH; Sancho JJ; Sitges-Serra A
BMJ; 1994 Sep; 309(6954):604-5. PubMed ID: 7993463
[No Abstract] [Full Text] [Related]
31. A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas.
Lange JR; Steinberg SM; Doherty GM; Langstein HN; White DE; Shawker TH; Eastman RC; Jensen RT; Norton JA
Surgery; 1992 Dec; 112(6):1033-7; discussion 1037-8. PubMed ID: 1455306
[TBL] [Abstract][Full Text] [Related]
32. Octreotide in the treatment of thoracic duct injuries.
Markham KM; Glover JL; Welsh RJ; Lucas RJ; Bendick PJ
Am Surg; 2000 Dec; 66(12):1165-7. PubMed ID: 11149591
[TBL] [Abstract][Full Text] [Related]
33. Treatment of a malignant enterocutaneous fistula with octreotide acetate.
Ayache S; Wadleigh RG
Cancer Invest; 1999; 17(5):320-1. PubMed ID: 10370359
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide.
Büyükyavuz I; Karnak I; Yiğit S; Tanyel FC
Turk J Pediatr; 2004; 46(3):289-91. PubMed ID: 15503489
[TBL] [Abstract][Full Text] [Related]
35. Treatment of fistulas of the gastrointestinal tract with total parenteral nutrition and octreotide in patients with carcinoma.
Spiliotis J; Briand D; Gouttebel MC; Astre C; Louer B; Saint-Aubert B; Kalfarentzos F; Androulakis J; Joyeux H
Surg Gynecol Obstet; 1993 Jun; 176(6):575-80. PubMed ID: 8322132
[TBL] [Abstract][Full Text] [Related]
36. Management of a high-output postoperative enterocutaneous fistula with a vacuum sealing method and continuous enteral nutrition.
Hyon SH; Martinez-Garbino JA; Benati ML; Lopez-Avellaneda ME; Brozzi NA; Argibay PF
ASAIO J; 2000; 46(4):511-4. PubMed ID: 10926156
[TBL] [Abstract][Full Text] [Related]
37. [Use of somatostatin analogue for intestinal and pancreatic fistulas].
Paran H; Neufeld D; Epstein T; Bendahan J; Freund U
Harefuah; 1991 Feb; 120(4):185-6. PubMed ID: 2066018
[TBL] [Abstract][Full Text] [Related]
38. [The somatostatin analog SMA (201-995) as adjuvant treatment in patients with external fistulae of the digestive system].
Castañón González JA; Miranda Ruíz R; Arías E; Fuentes Pintado E; Zárate Treviño A
Gac Med Mex; 1992; 128(3):285-8. PubMed ID: 1302733
[TBL] [Abstract][Full Text] [Related]
39. [A case of postoperative cutaneointestinal fistula responding to somatostatin analog, with a special reference to serum level of gastrointestinal hormones].
Katamura H; Ohki S; Sugita A; Ishihara S; Yamamoto M; Sugiyama M
Nihon Shokakibyo Gakkai Zasshi; 1994 May; 91(5):1037-41. PubMed ID: 8196198
[No Abstract] [Full Text] [Related]
40. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
Amiot A; Setakhr V; Seksik P; Allez M; Treton X; De Vos M; Laharie D; Colombel JF; Abitbol V; Reimund JM; Moreau J; Veyrac M; Flourié B; Cosnes J; Lemann M; Bouhnik Y
Am J Gastroenterol; 2014 Sep; 109(9):1443-9. PubMed ID: 25091063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
